Order of the President of the General Court of 26 November 2024.#Advanz Pharma Ltd v European Commission.#Interim relief – Medicinal products for human use – Orphan medicinal product for human use ‘Ocaliva – obeticholic acid’ – Revocation of a conditional marketing authorisation – Application for suspension of operation of a measure – No urgency.#Case T-455/24 R.